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Abstract
We describe here a patient with a recurrent hemangiopericytoma of the superior mediastinum
23 years after an initial complete resection. In the current biopsy specimen, the tumor cells
were much more anaplastic than those seen 23 years ago. Although the patient was treated with
chemotherapy, which consisted of ifosfamide and epirubicin, the tumor was unresponsive and
he died 6 months later from disease progression. Careful long-term follow-up is mandatory for
patients with hemangiopericytomas because recurrence with greater malignancy can develop fol-
lowing an extended disease-free interval.
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emangiopericytoma is an uncommon soft-tissue 
sarcoma ﬁ rst described by Stout and Murray 
in 1942 [1].  The origin of the tumor is pericytes, 
cells ﬁ rst deﬁ ned by Zimmermann [1,  2],  that are 
normally arranged around capillaries and postcapil-
lary venules and modulate blood ﬂ ow and permeabil-
ity.  Consequently,  they may occur anywhere capil-
laries are found.  Hemangiopericytomas occur most 
frequently in the extremities,  pelvis and retroperito-
neum,  head and neck,  and meninges,  and are rarely 
encountered in the mediastinum [2].  Here,  we 
describe a patient with a recurrent hemangiopericy-
toma of the superior mediastinum 23 years after an 
initial complete resection.
Case Report
　　An asymptomatic 69-year-old Japanese man was 
referred to us for further examination of a mediasti-
nal mass identiﬁ ed on January 1,  2003.  He had 
already undergone a complete excision of a mediasti-
nal tumor in our hospital 23 years previously.  The 
pathologic diagnosis at that time was reported as a 
probable thymoma with a pericytomatous pattern.
　　Physical examination on admission revealed no 
abnormalities.  Laboratory ﬁ ndings including tumor 
markers were within normal limits,  apart from mild 
anemia.  Serum tumor markers were not elevated, 
including cytokeratin 19 fragment,  carcinoembryonic 
antigen, 　ｸ-fetoprotein,  and human chorionic gonad-
otropin.  Plain radiography and computed tomography 
(CT) of the chest revealed a 10 × 8 cm mass in the 
anterior mediastinum (Fig.  1).  CT scans of the abdo-
men and brain and bone scintigraphy demonstrated no 
evidence of distant metastases.  The patient under-
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went percutaneous needle biopsy,  which revealed an 
irregular proliferation of anaplastic spindle cells 
with foci of pericytomatous patterns (Fig.  2A).  Most 
of the tumor cells were immunohistochemistrically 
reactive against vimentin and CD34,  and none of the 
tumor cells were reactive against cytokeratin AE1/
AE3,  epithelial membrane antigen,  factor Ⅷ,  S-100, 
desmin, 　ｸ-smooth muscle actin,  myoglobin, 
HBME-1,  synaptophysin,  or chromogranin A-3.  Two 
pathologists re-evaluated the hemtoxylin-eosin (HE)-
stained sections of the tumor that was resected 23 
years ago (Fig.  2B).  The histologic appearance was 
compatible with typical hemangiopericytoma,  and the 
tumor cells were much less anaplastic than those 
seen in the present biopsy specimen.  From these 
ﬁ ndings,  the present tumor was diagnosed as a recur-
rent primary mediastinal hemangiopericytoma with 
anaplastic changes.
　　Treatment was initiated February 24,  with che-
motherapy consisting of ifosfamide (1.5 g/m2) on days 
1 to 3 and epirubicin (60 mg/m2) on day 1.  The 
patient showed no response after completion of 2 
cycles of chemotherapy.  A systemic evaluation, 
including CT scans of the abdomen and brain and 
bone scintigraphy,  demonstrated new distant metas-
tases to the bone,  liver,  and brain.  The patient was 
discharged with supportive care.  He died 6 months 
later of disease progression.
Discussion
　　Hemangiopericytoma is a rare soft-tissue sarcoma 
derived from mesenchymal cells with pericytic diﬀ er-
entiation [1].  There are only a few published 
reports on this type of soft-tissue sarcoma ; informa-
tion on the clinical features and management of this 
tumor is seriously lacking.
　　Surgery remains the mainstay of treatment,  and 
the role of chemotherapy and irradiation has not yet 
been established,  because experience in the manage-
ment of this tumor is limited [3].  The overall prog-
nosis of this tumor is relatively favorable,  with 5- 
and 10-year actuarial survival rates of 86ｵ to 47ｵ, 
respectively [3ﾝ5].  The interval to disease recur-
rence in a previous report was longer than has been 
observed for other sarcomas.  One report stated that 
the median time to local recurrence after curative 
intent was 29 months (range,  2 to 225 months) [5].
　　Microscopic diagnosis is based primarily on the 
recognition of an architecture characterized by a 
pericytomatous pattern with tightly packed cells 
around ramifying thin-walled,  endothelium-lined vas-
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Fig. 1　　A chest plain radiography and computed tomography (CT) of the chest revealed a 10 × 8 cm anterior mediastinal mass.
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cular channels ranging from small capillary-sized ves-
sels to large gaping sinusoidal spaces [2,  6].  The 
pericytomatous pattern,  however,  occurs in a variety 
of benign and malignant neoplasms,  such as ﬁ brous 
histiocytoma,  synovial sarcoma,  mesenchymal chon-
drosarcoma,  angiosarcoma,  mesothelioma,  extra-
pleural solitary ﬁ brous tumor and others including 
thymoma [6].  Therefore,  distinguishing of heman-
giopericytoma from other tumors may be diﬃ  cult, 
especially when the characteristic features of other 
neoplasms are inconspicuous.
　　Recently,  immunostaining has become a powerful 
technique for deﬁ nitive diﬀ erentiation [7].  Our 
immunohistochemical examination demonstrated that 
the tumor was non-epithelial (vimentin-positive and 
cytokeratin-negative) and had CD34 antigens,  a 
marker of pericytes and hematopoietic progenitors. 
More than 20 years ago in Japan,  immunostaining 
was not available in routine examinations,  and histo-
logic examination was performed only with HE stain-
ing combined with other histochemical analyses. 
Therefore,  pathologists in the past faced greater dif-
ﬁ culties in the distinction of hemangiopericytoma 
from other tumors.
　　The diﬃ  culties of predicting the clinical behavior 
of hemangiopericytomas have been repeatedly 
stressed in the literature.  However,  Enzinger and 
Smith [2] in a review of 106 cases,  reported that a 
malignant clinical course is associated with a large 
tumor (greater than 5 cm),  an increased mitotic rate 
(greater than 3 mitotic ﬁ gures per HPF),  high cellu-
larity,  immature and pleomorphic tumor cells,  and 
foci of hemorrhage and necrosis.  In the present case, 
we evaluated HE sections of the primary tumor 
according to that criteria and found that none of the 
factors indicated a poorer prognosis,  though the cel-
lularity was somewhat high.  These ﬁ ndings might 
explain the very long interval to recurrence in this 
case.
　　On the other hand,  the recurrent tumor showed 
immature and pleomorphic (anaplastic) cells,  and the 
specimen was highly cellular.  The small biopsy speci-
men,  however,  did not allow us to check mitotic 
index,  hemorrhage or necrosis.  The anaplastic fea-
ture and the large size of the recurrent tumor may 
explain the resistance to chemotherapy and the devel-
opment of multiple metastases.  Even for recurrent 
cases,  the histologic features of hemangiopericyto-
mas should be taken into consideration for treatment 
strategy and prognosis.
　　The residual tumor cells after the initial excision 
likely grew and accumulated genetic and phenotypic 
changes to become more highly malignant at the time 
of clinical recurrence.  Few accounts have been found 
of such a highly anaplastic and malignant change in a 
recurrent hemangiopericytoma ; therefore,  our case 
serve as an important warning of that risk.
　　In summary,  we describe a patient with recurrent 
hemangiopericytoma of the superior mediastinum 23 
years after initial curative resection.  Careful long-
199Recurrence of Mediastinal HemangiopericytomaJune 2006
A B
Fig. 2　　Histologic ﬁ ndings of the hemangiopericytoma relapse (A) and on the ﬁ rst presentation 23 years ago (B).  (Hematoxylin and 
eosin stain ; original magniﬁ cation,  × 200).
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term follow-up is mandatory for patients with heman-
giopericytomas because recurrence with greater 
malignancy can develop following an extended dis-
ease-free interval.
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